Home › Funds › PFM Health Sciences, LP › CVS

PFM Health Sciences, LP position in CVS

CVS HEALTH CORP · Consumer Staples

PFM Health Sciences, LP reported holding 137,457 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$14.2M, representing 1.25% of its reported portfolio and ranking #29 among its reported holdings. PFM Health Sciences, LP has disclosed CVS holdings in 5 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)137.46K sh
Reported value held$14.22M
Portfolio Weight1.25%
First reportedQ1 2025
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's CVS position evolved

PFM Health Sciences, LP first disclosed a stake in CVS in Q1 2025 at 312,305 shares (US$21.2M). The position peaked in Q2 2025 at 479,005 shares, worth US$33.0M. Across 5 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 137,457 shares valued at US$14.2M. Notable position changes include a 53% increase in Q2 2025 (shares rose 10% over the following quarter), a 28% trim in Q3 2025 (shares rose 6% over the following quarter), a 69% trim in Q4 2025 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 312.31K $21.16M New
Q2 2025 479.00K $33.04M Add
Q3 2025 346.68K $26.14M Reduce
Q4 2025 107.77K $8.55M Reduce
Q2 2026 137.46K $14.22M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has PFM Health Sciences, LP held CVS?

PFM Health Sciences, LP has disclosed CVS holdings in 5 of the last 6 reported quarters, going back to Q1 2025.

What is PFM Health Sciences, LP's current position in CVS?

As of Q2 2026, PFM Health Sciences, LP holds 137.46K shares of CVS (CVS HEALTH CORP), valued at $14.22M, representing 1.25% of its reported portfolio and ranking #29.

Has PFM Health Sciences, LP been buying or selling CVS?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP newly opened its position in CVS. The position peaked in Q2 2025 at 479.00K shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.